Seitaro Yoshida

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)

Yoshikazu Nakaoka, Mitsuaki Isobe, Syuji Takei et al. · Annals of the Rheumatic Diseases · 2017 · 386 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors

Midori Shima, Keiji Nogami, Sayaka Nagami et al. · Haemophilia · 2019 · 156 citations · Full text

Medicine, Hematology, Pharmacology +11

A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia

Yoshio Hirayasu, Shinichi Sato, Hideaki Takahashi et al. · BMC Psychiatry · 2016 · 31 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Increased Bone Mineral Density with Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients with Primary Osteoporosis: Three-Year Analysis of the MOVER Study

Hiroshi Hagino, Seitaro Yoshida, Junko Hashimoto et al. · Calcified Tissue International · 2014 · 20 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Effect of monthly intravenous ibandronate injections on vertebral or non-vertebral fracture risk in Japanese patients with high-risk osteoporosis in the MOVER study

Masako Ito, Masato Tobinai, Seitaro Yoshida et al. · Journal of Bone and Mineral Metabolism · 2015 · 15 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13